Tobinai K - Search Results

1

[Treatment of B-cell lymphoma with a chimeric anti-CD20 monoclonal antibody(rituximab)].

Tobinai K. Tobinai K. Nihon Rinsho. 2002 Jan;60(1):95-9. Nihon Rinsho. 2002. PMID: 11808346 Review. Japanese.

2

[Rituximab, a chimeric mouse-human anti-CD20 monoclonal antibody].

Tobinai K. Tobinai K. Nihon Rinsho. 2002 Mar;60(3):468-72. Nihon Rinsho. 2002. PMID: 11904960 Review. Japanese.

3

[Rituximab, a chimeric anti-CD20 monoclonal antibody, in the treatment of B-cell lymphoma].

Tobinai K. Tobinai K. Gan To Kagaku Ryoho. 2002 Mar;29(3):473-80. Gan To Kagaku Ryoho. 2002. PMID: 11915743 Review. Japanese.

4

Report of the fifteenth international symposium of the foundation for promotion of cancer research: new horizons in the diagnosis and treatment of hematological malignancies based on molecular genetic features.

Multani PS, Tobinai K, Kakizoe T, Armitage JO, Ohno R, Sugimura T. Multani PS, et al. Among authors: tobinai k. Jpn J Clin Oncol. 2002 Sep;32(9):371-85. doi: 10.1093/jjco/hyf080. Jpn J Clin Oncol. 2002. PMID: 12417606

5

Monoclonal antibody therapy for B-cell lymphoma: clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan.

Tobinai K. Tobinai K. Int J Hematol. 2002 Dec;76(5):411-9. doi: 10.1007/BF02982806. Int J Hematol. 2002. PMID: 12512835 Review.

6

Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report.

Kataoka I, Arima F, Nishimoto J, Watanabe T, Kobayashi Y, Tamura R, Yamamoto S, Matsuno Y, Shimoda T, Tobinai K. Kataoka I, et al. Among authors: tobinai k. Jpn J Clin Oncol. 2002 Dec;32(12):546-9. doi: 10.1093/jjco/hyf107. Jpn J Clin Oncol. 2002. PMID: 12578905

7

[New trends in the diagnosis and treatment of malignant lymphoma].

Tobinai K. Tobinai K. Nihon Igaku Hoshasen Gakkai Zasshi. 2003 Feb;63(3):81-8. Nihon Igaku Hoshasen Gakkai Zasshi. 2003. PMID: 12692961 Review. Japanese.

8

Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.

Tobinai K. Tobinai K. Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S90-6. doi: 10.1007/s00280-003-0595-y. Epub 2003 Jun 18. Cancer Chemother Pharmacol. 2003. PMID: 12819934 Review.

9

Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma.

Tobinai K, Uike N, Saburi Y, Chou T, Etoh T, Masuda M, Kawano F, Matsuoka M, Taguchi H, Makino T, Asano Y, Tamura K, Ohashi Y; Cladribine/ATL Study Group, Japan. Tobinai K, et al. Int J Hematol. 2003 Jun;77(5):512-7. doi: 10.1007/BF02986621. Int J Hematol. 2003. PMID: 12841391 Clinical Trial.

10

Rituximab and other emerging antibodies as molecular target-based therapy of lymphoma.

Tobinai K. Tobinai K. Int J Clin Oncol. 2003 Aug;8(4):212-23. doi: 10.1007/s10147-003-0295-y. Int J Clin Oncol. 2003. PMID: 12955576 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters